Tecentriq Hybreza is part of the PD-1/PD-L1 Inhibitors class and treats Lung Cancer, Soft Tissue Sarcoma, Liver Cancer and other conditions. PD-1/PD-L1 Inhibitors are used to treat melanoma that has metastasized or that can't be surgically removed. They suppress a protein that can keep the immune system from recognizing and attacking cancer cells. Tecentriq Hybreza is only available as a brand name drug.